World Solve

antibiotic resistance growing remains one of the most urgent challenges of our time. Systems currently in place are inadequate for the scale and complexity of the problem. A successful approach must work where resources are scarcest and demonstrate clear, measurable results. It should identify possible harms, respect local agency, and show how the solution can be maintained and expanded by the communities it is meant to serve.

Research environments may unintentionally create or amplify resistance traits that escape through waste, personnel, or supply chains. Robust solutions must combine laboratory engineering, surveillance, waste treatment, and international reporting. The solution must work with limited capital, intermittent services, and local maintenance capacity. The research opportunity is to define measurable success criteria, test the approach in realistic settings, identify failure modes, and create a pathway from prototype to accountable deployment.

Over the next two decades, rising resistance in bacteria, fungi, and parasites risks undermining surgery, chemotherapy, and intensive care. Global surveillance networks, rapid diagnostics, and new antimicrobial development platforms are crucial to avert a post-antibiotic era.

Resistance genes move through soil, water, and food chains, making hospital-focused interventions insufficient. One-Health regulatory frameworks and monitoring tools are required.

Poor-quality medicines accelerate resistance and treatment failure. Track-and-trace systems and quality-testing infrastructure are needed.

Overuse of antibiotics in health and agriculture breeds resistant pathogens. Stewardship programs and rapid diagnostics can reduce misuse.

Unregulated over-the-counter antibiotic sales and heavy use in livestock farming are breeding drug-resistant bacteria. Point-of-care rapid diagnostics could reduce unnecessary prescriptions.

Resistance to insecticides and antimalarial drugs is rising, and many rural clinics lack rapid diagnostic tools. Better low-cost diagnostics, vaccines with longer efficacy, and resistance-tracking data platforms are urgently needed.

Weak regulatory enforcement lets fake antimalarials and antibiotics reach patients, worsening drug resistance and deaths. Blockchain-based drug verification and stronger customs screening are promising solutions.

Pressurized gloves force astronauts to constantly fight suit resistance, leading to fingernail loss and severe hand fatigue. Robotic assistance exoskeletons or active pressure-sensing glove joints are needed.

In major agricultural and industrial manufacturing regions across East and South Asia, overuse of antibiotics in livestock and unmonitored factory discharge have accelerated the proliferation of drug-resistant pathogens, threatening global healthcare systems.

Asia operates hundreds of young, high-emitting coal plants protected by long-term power purchase agreements. Early retirement initiatives face severe financial losses and political resistance from domestic energy sectors.

Over-application of agrochemicals has accelerated insect resistance in rice and vegetable farming, causing sudden pest outbreaks and severe localized crop failures.

Poor supply chain oversight allows fake antibiotics, malaria medications, and life-saving drugs to enter rural retail markets, leading to treatment failures and drug resistance.

Resistant malaria strains have emerged in certain regions and are gradually spreading, threatening to undermine decades of progress against the disease. Coordinated, faster response to contain resistance before it spreads further remains incomplete.

Current malaria prevention still depends heavily on physical barriers and insecticides, both of which face growing resistance and logistical challenges in the regions most affected. A more durable prevention method remains an urgent unmet need.

Bacteria evolve resistance faster than new antibiotics are being developed and approved, creating a widening treatment gap. Without new approaches, once-treatable infections could become far deadlier again.

Antibiotics are widely used in livestock farming to prevent disease and promote growth, contributing significantly to antibiotic resistance in humans. Reducing this use without harming farmers' livelihoods remains a persistent unresolved challenge.

Tuberculosis remains a major killer in some regions, and drug-resistant strains are becoming harder and more expensive to treat. Slowing this resistance requires both better medicine access and improved treatment adherence support.

A small number of people show natural resistance to certain infections or conditions, and understanding why could reveal entirely new treatment approaches. This resistance remains only partially understood at a genetic level.